SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-13-065183
Filing Date
2013-12-02
Accepted
2013-12-02 21:42:59
Documents
2
Period of Report
2013-11-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v362020_3.html 3  
1 OWNERSHIP DOCUMENT v362020_3.xml 3 4125
2 EXHIBIT 24 v362020_ex24.htm EX-24 8431
  Complete submission text file 0001144204-13-065183.txt   14178
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O COMPETITIVE TECHNOLOGIES, INC. 777 COMMERCE DRIVE, SUITE 100 FAIRFIELD CT 06825
Business Address
DUNBAR GEORGE W JR (Reporting) CIK: 0001194712 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34058 | Film No.: 131253035